{
    "nctId": "NCT01837563",
    "briefTitle": "Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer",
    "officialTitle": "Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Locally Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 36,
    "primaryOutcomeMeasure": "Objective Response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Locally advanced breast cancer, with or without metastatic disease\n2. Patient to receive systemic therapy\n3. Breast size and epithelial integrity adequate to allow alternate imaging exams.\n4. Patient able to provide written informed consent.\n5. No serious associated psychiatric illness\n6. Age \u2265 18 years old\n\nExclusion Criteria:\n\n1. Cardiac pacemaker\n2. Any implanted electronic device\n3. Severe claustrophobia\n4. Allergy to the MRI contrast agent gadolinium",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}